Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine.

@article{Papi2009LongtermPO,
  title={Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine.},
  author={C Cortez Papi and Annalisa Aratari and Valentina Tornatore and Maurizio Koch and Lucio Capurso and Renzo Caprilli},
  journal={Journal of Crohn's & colitis},
  year={2009},
  volume={3 2},
  pages={
          109-14
        }
}
BACKGROUND Prevention of post-operative recurrence has a central role in the management of Crohn's Disease (CD). Many drugs have been evaluated in prospective randomised controlled trials (RCTs) but the results are disappointing. Mesalazine, the drug more extensively investigated, has been shown to be effective for preventing recurrence in the short-term; however, the overall benefit is small and no data are available on the long-term effectiveness. AIM To compare the long-term occurrence of… CONTINUE READING

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 32 REFERENCES

Long-term clinical results of ileocecal resection for Crohn's disease

G Cullen, A O' Toole, D Keegan
  • Inflamm Bowel Dis 2007;13(11):1369–1373
  • 2007